On the filings, BXP (BXP) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
Asset-rich life-science REIT trading ~its multiple with a covered ~11% yield, but revenue is now shrinking and impairments are mounting.
Premier-office REIT riding the flight-to-quality with $1.25B operating cash flow, but 3.59x leverage and a dividend above earnings cap upside.
| Metric | ARE | BXP |
|---|---|---|
| Fundamentals score | 33 | 75 |
| Revenue growth (YoY) | -2.9% | +2.2% |
| Net income growth (YoY) | -542.7% | +1839.5% |
| Net margin | -47.2% | 7.9% |
| Return on equity | -9.2% | 5.4% |
| ROIC (est.) | — | 8.5% |
| Liabilities / Equity | 0.96 | 3.59 |
| Piotroski F-score | 3 / 9 | 5 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 9, 2026, 9:34 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:46 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.